The ADC binds HER2 (not topoisomerase I), is internalized, and releases DXd, which inhibits topoisomerase I to cause DNA damage and apoptosis; killing is driven by HER2 targeting with possible bystander effect and ADCC, not by topoisomerase I expression itself.